Brand Name: IRINOTECAN VIATRIS INJECTION, SOLUTION, CONCENTRATE PARENTERAL 20 mg/1mL 5mL
Generic Name: IRINOTECAN HYDROCHLORIDE INJECTION, SOLUTION, CONCENTRATE PARENTERAL 20 mg/1mL 5MILLILITER
Indication: Irinotecan is indicated for the treatment of patient advanced colorectal cancer:
- In combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for advanced disease,
- As a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen.
Dosage Forms: Irinotecan 100mg/5ml, Vial 100mg/5ml
Rout of Administration: Intravenous use only
Storage:
- To be stored at a temperature not exceeding 25°C.
- Do not freeze
Manufacturer : Viatris Sante
Country: France

